Lead: Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Lead: Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Addiction

This study used a microsimulation model of methamphetamine use behavior among individuals with methamphetamine use disorder (MethUD) to assess the cost-effectiveness of contingency management (CM) for MethUD. Both 12-week and 24-week CM programs were modeled, using a maximum incentive of $750/patient, per SAMHSA guidelines. The model simulation was run for a cohort of 10,000 individuals with MethUD and looked at lifetime cost. Compared to no treatment, the model predicted an estimated net gain of 0.70 QALYs per person at a cost of $6850/QALY for a 12-week program, with an incremental cost-effectiveness ratio (ICER) of $9830/QALY. For a 24-week program, the benefit was 0.81 QALYs at a cost of $10,000, yielding an ICER of $12,312/QALY. This suggests that both durations of CM for MethUD are highly cost-effective, even at the maximum level of incentives.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(100)

Lead: Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population-based interrupted time series study

Lead: Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population-based interrupted time series study

Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population-based interrupted time series study Addiction Adolescent past-year cannabis use trends ha...

29 Sep 7min

Lead: Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024

Lead: Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024

Abandonment of prescribed buprenorphine for opioid use disorder, 2020-2024 JAMA Network Open This retrospective cohort study examined characteristics associated with abandonment of newly prescribed bu...

22 Sep 8min

Lead: US drug overdose deaths involving stimulants without opioids continued to rise in 2024

Lead: US drug overdose deaths involving stimulants without opioids continued to rise in 2024

US drug overdose deaths involving stimulants without opioids continued to rise in 2024 Addictive Behaviors Reports Drug overdose deaths (DOD) peaked in 2022 before a decline in rates driven by decreas...

15 Sep 7min

Lead: US drug overdose deaths that occurred in isolation, 2022–2024

Lead: US drug overdose deaths that occurred in isolation, 2022–2024

US drug overdose deaths that occurred in isolation, 2022–2024 NEJM Evidence Data were obtained from SUDORS (State Unintentional Drug Overdose Reporting System) for 2022-2024. Of 191,577 overdose death...

9 Sep 7min

Lead: Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians

Lead: Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians

Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians Journal of the American Medical Association This Special Communication summarizes the evidence on the use ...

3 Sep 7min

Lead: Oral semaglutide for alcohol use disorder: A randomized clinical trial

Lead: Oral semaglutide for alcohol use disorder: A randomized clinical trial

Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial The American Journal of Psychiatry Accumulating preclinical and observational evidence suggests that glucagon-like peptide-1 rece...

25 Aug 7min

Lead: Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic

Lead: Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic

Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic Journal of Substance Use and Addiction Treatment This is an ...

18 Aug 7min

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction Cocaine use disorder (CUD) is an increasingly wi...

11 Aug 7min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
aftenpodden-usa
popradet
fotballpodden-2
stopp-verden
dine-penger-pengeradet
det-store-bildet
rss-espen-lee-usensurert
rss-gukild-johaug
saken
nokon-ma-ga
hanna-de-heldige
aftenbla-bla
rss-ness
rss-penger-polser-og-politikk
e24-podden
bt-dokumentar-2
frokostshowet-pa-p5